Astera Labs, Inc. (ALAB)
(Real Time Quote from BATS)
$52.32 USD
+0.68 (1.32%)
Updated Jul 22, 2024 11:12 AM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Balance Sheet
Fiscal Year End for Astera Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 149 | 163 | -99,999 | -99,999 | -99,999 |
Receivables | 8 | 11 | NA | NA | NA |
Notes Receivable | 0 | 0 | NA | NA | NA |
Inventories | 24 | 29 | NA | NA | NA |
Other Current Assets | 4 | 3 | NA | NA | NA |
Total Current Assets | 186 | 206 | NA | NA | NA |
Net Property & Equipment | 5 | 4 | NA | NA | NA |
Investments & Advances | 0 | 0 | NA | NA | NA |
Other Non-Current Assets | 0 | 0 | NA | NA | NA |
Deferred Charges | 0 | 0 | NA | NA | NA |
Intangibles | 0 | 0 | NA | NA | NA |
Deposits & Other Assets | 6 | 2 | NA | NA | NA |
Total Assets | 196 | 212 | NA | NA | NA |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | NA | NA | NA |
Accounts Payable | 6 | 10 | NA | NA | NA |
Current Portion Long-Term Debt | 0 | 0 | NA | NA | NA |
Current Portion Capital Leases | 0 | 0 | NA | NA | NA |
Accrued Expenses | 29 | 30 | NA | NA | NA |
Income Taxes Payable | 0 | 0 | NA | NA | NA |
Other Current Liabilities | 0 | 0 | NA | NA | NA |
Total Current Liabilities | 35 | 40 | NA | NA | NA |
Mortgages | 0 | 0 | NA | NA | NA |
Deferred Taxes/Income | 0 | 0 | NA | NA | NA |
Convertible Debt | 0 | 0 | NA | NA | NA |
Long-Term Debt | 0 | 0 | NA | NA | NA |
Non-Current Capital Leases | 0 | 0 | NA | NA | NA |
Other Non-Current Liabilities | 259 | 257 | NA | NA | NA |
Minority Interest (Liabilities) | 0 | 0 | NA | NA | NA |
Total Liabilities | 294 | 297 | NA | NA | NA |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | NA | NA | NA |
Common Stock (Par) | 0 | 0 | NA | NA | NA |
Capital Surplus | 27 | 14 | NA | NA | NA |
Retained Earnings | -125 | -99 | NA | NA | NA |
Other Equity | 0 | 0 | NA | NA | NA |
Treasury Stock | 0 | 0 | NA | NA | NA |
Total Shareholder's Equity | -98 | -85 | NA | NA | NA |
Total Liabilities & Shareholder's Equity | 196 | 212 | NA | NA | NA |
Total Common Equity | -98 | -85 | 0 | 0 | 0 |
Shares Outstanding | NA | NA | NA | NA | NA |
Book Value Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Fiscal Year End for Astera Labs, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 801 | 149 | -99,999 | -99,999 |
Receivables | NA | 17 | 8 | NA | NA |
Notes Receivable | NA | 0 | 0 | NA | NA |
Inventories | NA | 30 | 24 | NA | NA |
Other Current Assets | NA | 7 | 4 | NA | NA |
Total Current Assets | NA | 854 | 186 | NA | NA |
Net Property & Equipment | NA | 8 | 5 | NA | NA |
Investments & Advances | NA | 0 | 0 | NA | NA |
Other Non-Current Assets | NA | 0 | 0 | NA | NA |
Deferred Charges | NA | 0 | 0 | NA | NA |
Intangibles | NA | 0 | 0 | NA | NA |
Deposits & Other Assets | NA | 3 | 6 | NA | NA |
Total Assets | NA | 865 | 196 | NA | NA |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | NA | NA |
Accounts Payable | NA | 11 | 6 | NA | NA |
Current Portion Long-Term Debt | NA | 0 | 0 | NA | NA |
Current Portion Capital Leases | NA | 0 | 0 | NA | NA |
Accrued Expenses | NA | 34 | 29 | NA | NA |
Income Taxes Payable | NA | 0 | 0 | NA | NA |
Other Current Liabilities | NA | 0 | 0 | NA | NA |
Total Current Liabilities | NA | 46 | 35 | NA | NA |
Mortgages | NA | 0 | 0 | NA | NA |
Deferred Taxes/Income | NA | 0 | 0 | NA | NA |
Convertible Debt | NA | 0 | 0 | NA | NA |
Long-Term Debt | NA | 0 | 0 | NA | NA |
Non-Current Capital Leases | NA | 0 | 0 | NA | NA |
Other Non-Current Liabilities | NA | 259 | NA | NA | |
Minority Interest (Liabilities) | NA | 0 | 0 | NA | NA |
Total Liabilities | NA | 56 | 294 | NA | NA |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | NA | NA |
Common Stock (Par) | NA | 0 | 0 | NA | NA |
Capital Surplus | NA | 1,027 | 27 | NA | NA |
Retained Earnings | NA | -218 | -125 | NA | NA |
Other Equity | NA | 0 | 0 | NA | NA |
Treasury Stock | NA | 0 | 0 | NA | NA |
Total Shareholder's Equity | NA | 809 | -98 | NA | NA |
Total Liabilities & Shareholder's Equity | NA | 865 | 196 | NA | NA |
Total Common Equity | 0 | 809 | -98 | 0 | 0 |
Shares Outstanding | 155.70 | 152.50 | NA | NA | NA |
Book Value Per Share | 0.00 | 5.30 | 0.00 | 0.00 | 0.00 |